MedPath

The effect of ContrAst media Temperature on patient comfort in Computed tomograpHYof the abdomen. (CATCHY trial)

Completed
Conditions
Alle aandoeningen waarvoor een patient een CT in portaal veneuze fase krijgt.
Abdominal diseases
10017990
10027476
Registration Number
NL-OMON48194
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
216
Inclusion Criteria

Patients referred for a CT of the abdomen
Patients >= 18 and competent to sign an informed consent.

Exclusion Criteria

o Hemodynamic instability
o Pregnancy
o Renal insufficiency defined as glomerular filtration rate (GFR)
<30mL/min/1.73m2 (Odin protocol 004720)
o Iodine allergy (Odin protocol 022199)
o Age < 18 year
o Unable to give informed consent or no informed consent obtained
o Inability to position an 18 gauge cannula in an antecubital vein

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To evaluate the degree of patient discomfort during the injection of CM at room<br /><br>temperature (20*C) with a concentration of 300 mg/ml, compared to pre-warmed CM<br /><br>(37*C). We hypothesize that there is a disadvantage in patient comfort when CM<br /><br>is not preheated. We will evaluate general comfort levels, as well as vasovagal<br /><br>reactions, CM extravasation, shivering, cold feeling and goosebumps after CM<br /><br>injection. It is expected that the differences in CM temperatures will not<br /><br>influence subjective and objective IQ. Th</p><br>
Secondary Outcome Measures
NameTimeMethod
<p> Injection parameters (e.g. time to peak, bolus homogeneity and time pressure<br /><br>curve) will be evaluated. </p><br>
© Copyright 2025. All Rights Reserved by MedPath